跳至主要内容
临床试验/CTRI/2019/07/020460
CTRI/2019/07/020460已完成2 期

A randomized controlled clinical study to evaluate the effect of Sookshma Eladi choornam in Hyperlipidaemias

B Harinatha chary1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年12月8日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Lipid profile

研究概览

简要总结

This study is a randomized controlled trial comparing the safety and efficacy of Sookshma Eladi choornam 3 grm BID orally and Atorvastatin orally  for 3 months in 100 patients of Hyperlipidaemias. The study was completed on 23-7-2020.  Total number of dropouts in the study were 5 patients. The observations and results were obtained. Statistical analysis done.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of age group between 30 years and
  • Patients of either gender.
  • (Females not on oestrogen therapy) Patients with HTN, DM and Obesity.

排除标准

  • Hyperlipidaemias due to 1.Genetic causes 2.Thyroid abnormalities 5.Alcohol abuse 4.familial hypercholesterolemia
  • Significant hepatic or renal function test abnormalities 6.Drug intake : Corticosteroids, Diuretics, Beta-blockers, Oral contraceptives, Cyclosporin, Androgens & Retinoids.

结局指标

主要结局

Lipid profile

时间窗: 3 months

次要结局

  • BMI(90 days)

研究者

发起方
B Harinatha chary
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验